Hims & Hers stock has dropped over 60% from its peak due to concerns about its GLP-1 business. Read why I think HIMS stock is ...

A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...

If you are taking a weight loss medication such as Ozempic, Wegovy, or Zepbound for obesity or other health concerns, you may ...

A high-dose solution for those with critically low vitamin D levels. Vitamin D3 may support immune function, bone health, mood, and Vitamin D repletion. A critical safety solution for patients ...

A new weight loss drug that's being trialled as a daily pill and could rival Ozempic has delivered some astonishing results.

Dispensations of tirzepatide and semaglutide increased significantly in recent years while the use of other glucose-lowering ...

Lexaria Bioscience (LEXX) provides a glucagon-like peptide-1 strategic update following important industry developments reported both by Pfizer ...

Discover Mounjaro Tirzepatide's impact on obesity in India post its March launch. Get insights on effectiveness against ...

Some dosage strengths of both Victoza and Saxenda are included on the FDA's shortages list, mainly due to pressures on Novo Nordisk's production capacity for its entire GLP-1 franchise ...

A man who lost over three stone in as many months via the weight loss medicine Mounjaro has admitted to making a 'big mistake ...

Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...